K. Jin

发表

Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients

Xianjun Yu, Chen Liu, Q. Ni, 2020, Cancer management and research.

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas

Xianjun Yu, Chen Liu, Q. Ni, 2020, Experimental and therapeutic medicine.

Laparoscopic Versus Open Incisional and Ventral Hernia Repair: A Systematic Review and Meta-analysis

Yanyan Zhang, Zhi-qian Hu, Can Cao, 2014, World Journal of Surgery.

Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma.

Xianjun Yu, Chen Liu, Q. Ni, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms

L. Shen, Rong Lin, M. Qiu, 2019, Cancer medicine.

AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN

Xianjun Yu, Chen Liu, Jin Xu, 2019, World Journal of Surgical Oncology.

Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs

J. Li, Q. Zhang, Jingnan Li, 2017, BMC Cancer.

Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET).

Minhu Chen, Rong Lin, M. Qiu, 2016, International journal of oncology.

The role of necroptosis in cancer biology and therapy

Chao Yang, Xianjun Yu, Chen Liu, 2019, Molecular Cancer.

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Zuqiang Liu, J. Long, Xianjun Yu, 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Hexokinase 2 dimerization and interaction with voltage‐dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer

Xianjun Yu, Chen Liu, Chao Yang, 2019, Cancer medicine.

Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer

Zuqiang Liu, J. Long, Xianjun Yu, 2017, Annals of Surgical Oncology.

Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).

Xiao‐Yu Yin, C. Shao, Zheng Wu, 2017, International journal of oncology.

Systematic Review and Meta-Analysis of Somatostatin Analogues in the Prevention of Postoperative Complication after Pancreaticoduodenectomy

Zhi-qian Hu, Yi Wang, K. Jin, 2015, Digestive Surgery.

Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer

Zhenyu Liao, Wei Wu, Wu-Hu Zhang, 2022, EBioMedicine.

Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer.

Xianjun Yu, Chen Liu, Q. Ni, 2017, International journal of oncology.

Distribution of Lewis and Secretor polymorphisms and corresponding CA19‐9 antigen expression in a Chinese population

R. Lu, J. Long, Xianjun Yu, 2017, FEBS open bio.

Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors

Xianjun Yu, Chen Liu, Q. Ni, 2020, Pancreas.

Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors.

Jie Chen, Wenquan Wang, H. Gao, 2017, Oncology letters.

Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China.

Bo-Heng Zhang, J. Long, Xianjun Yu, 2017, Oncology letters.

Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.

elliot k fishman, A. Javed, L. Shen, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Revised nodal stage for pancreatic neuroendocrine tumors.

B. Zhang, H. Gao, J. Long, 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer

Wei Wu, Longyun Ye, K. Jin, 2022, Frontiers in Immunology.

Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer.

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Abstract. Carbohydrate antigen 19-9 (CA19-9) is the most important biomarker for pancreatic cancer. Approximately 5-10% of individuals are Lewis antigen negative with scarce secretion of CA19‐9 and fucosylation deficiency. However, the characteristics of Lewis-negative pancreatic cancer are uniden-

Xianjun Yu, Chen Liu, Q. Ni, 2020 .

Special issue “The advance of solid tumor research in China”: Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors

Wei Wang, Jie Chen, S. Feng, 2022, International journal of cancer.

Focus on mast cells in the tumor microenvironment: Current knowledge and future directions.

Wei Wu, Longyun Ye, K. Jin, 2022, Biochimica et biophysica acta. Reviews on cancer.

Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms

Xianjun Yu, Chen Liu, G. Luo, 2021, Cancer management and research.

CMAR_A_275173 107..115

Xianjun Yu, Chen Liu, G. Luo, 2021 .

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2020, Journal of Hematology & Oncology.

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.

A. Warshaw, R. Lu, J. Long, 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

TGF-β1-induced RAP2 regulates invasion in pancreatic cancer

Wei Wu, Chen Liu, Qiuyi Huang, 2022, Acta biochimica et biophysica Sinica.

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients

Xianjun Yu, Liang Liu, Chen Liu, 2017, International journal of cancer.

Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer

Xianjun Yu, Chen Liu, Chao Yang, 2020, Annals of Surgical Oncology.

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

Yi Qin, Bo Zhang, Jin Xu, 2016, Cancer letters.

Pancreatic cancer: BRCA mutation and personalized treatment

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Expert review of anticancer therapy.

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.

Xianjun Yu, Chen Liu, Q. Ni, 2020, Biochimica et biophysica acta. Reviews on cancer.

(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.

Dan Huang, Zuqiang Liu, J. Long, 2014, International journal of oncology.

F-FDG PET / CT can be used to detect non-functioning pancreatic neuroendocrine tumors

Dan Huang, Zuqiang Liu, J. Long, 2014 .

Innate Lymphoid Cells: Emerging Players in Pancreatic Disease

Wei Wu, K. Jin, Zhiwen Xiao, 2022, International journal of molecular sciences.

Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome Sequencing

J. Long, Xianjun Yu, Chen Liu, 2017, International journal of molecular sciences.

The role of necroptosis in cancer biology and therapy

Chao Yang, Xianjun Yu, Chen Liu, 2019, Molecular Cancer.

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

P. Chiao, Xianjun Yu, Liang Liu, 2016, Clinical Cancer Research.

Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China

Minhu Chen, Jie Chen, L. Xue, 2017, Cancer Chemotherapy and Pharmacology.

Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma

Chao Yang, Xianjun Yu, Chen Liu, 2018, Cancer Immunology, Immunotherapy.

Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy

Zuqiang Liu, J. Long, Xianjun Yu, 2014, Annals of Surgical Oncology.

High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour

Xianjun Yu, Chen Liu, Q. Ni, 2020, Endocrine.

A Ki-67 Index to Predict Treatment Response to the Capecitabine/Temozolomide Regimen in Neuroendocrine Neoplasms: A Retrospective Multicenter Study

Wei Wang, Jie Chen, Xianjun Yu, 2020, Neuroendocrinology.

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions

Xianjun Yu, Chen Liu, G. Luo, 2018, Journal of Hematology & Oncology.

Prognosis of distal pancreatic cancers controlled by stage

Xianjun Yu, Chen Liu, Q. Ni, 2020, Experimental and therapeutic medicine.

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients

Xianjun Yu, Chen Liu, Jin Xu, 2020, Cancer medicine.

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.

Zuqiang Liu, J. Long, Xianjun Yu, 2017, Cancer letters.

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Drug design, development and therapy.

KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer.

Xianjun Yu, Chen Liu, Jin Xu, 2019, Cancer letters.

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

R. Lu, J. Long, Xianjun Yu, 2017, Annals of surgery.

Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients.

Zuqiang Liu, J. Long, Xianjun Yu, 2017, Oncology letters.

Body Composition and Response and Outcome of Neoadjuvant Treatment for Pancreatic Cancer

Xianjun Yu, Chen Liu, K. Jin, 2021, Nutrition and cancer.

Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review

J. Long, Xianjun Yu, Q. Ni, 2019, Annals of Surgical Oncology.

Lewis antigen-negative pancreatic cancer: An aggressive subgroup

Xianjun Yu, Chen Liu, Q. Ni, 2020, International journal of oncology.

Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors

Minhu Chen, Wei Wang, Jie Chen, 2017, Oncology letters.

MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.

Xianjun Yu, Chen Liu, G. Luo, 2018, Cancer letters.

Critical role of oncogenic KRAS in pancreatic cancer (Review).

Xianjun Yu, Liang Liu, S. Ji, 2016, Molecular medicine reports.

Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.

Jie Chen, J. Long, Xianjun Yu, 2017, Oncology letters.

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Tissue‐resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression

Wei Wu, Tianjiao Li, Longyun Ye, 2023, International journal of cancer.

Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor.

Wenquan Wang, H. Gao, Hua-Xiang Xu, 2018, Cancer letters.

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.

Zuqiang Liu, J. Long, Xianjun Yu, 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Single Incision versus Conventional Multiport Laparoscopic Appendectomy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

K. Jin, Haiyang Zhou, Yanping Sun, 2014, Digestive Surgery.

Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes.

Dan Huang, Xianjun Yu, Chen Liu, 2019, Pancreas.

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

J. Long, Xianjun Yu, Liang Liu, 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer

Xianjun Yu, Chen Liu, Q. Ni, 2019, Cancer management and research.

Development and Validation of a Prognostic Nomogram to Guide Decision-Making for High-Grade Digestive Neuroendocrine Neoplasms.

Gang Wu, Shengli Yang, Jie Chen, 2019, The oncologist.

VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1α Up-Regulation.

S. Ji, S. Shi, C. Liu, 2016, Current molecular medicine.

Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs

J. Li, Q. Zhang, Jingnan Li, 2017, BMC Cancer.

Predictive Values of Preoperative Markers for Resectable Pancreatic Body and Tail Cancer Determined by MDCT to Detect Occult Metastases

Xianjun Yu, Chen Liu, G. Luo, 2021, World Journal of Surgery.

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer

Dan Huang, Zuqiang Liu, J. Long, 2016, International journal of molecular sciences.

Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma

J. Long, Xianjun Yu, Chen Liu, 2018, Pancreas.

The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.

Z. Wang, G. Luo, H. Cheng, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR.

Chao Yang, Xianjun Yu, Chen Liu, 2020, Acta biochimica et biophysica Sinica.

Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and its Clinical Significance.

Taiping Zhang, K. Jin, Yuan-jia Chen, 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.

Chao Li, Xianjun Yu, S. Ji, 2016, Current molecular medicine.

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

Xianjun Yu, Chen Liu, Q. Ni, 2020, Cancer control : journal of the Moffitt Cancer Center.

High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2021, World Journal of Surgical Oncology.

Stromal Organization as a Predictive Biomarker of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer

K. Jin, Haiyang Zhou, Hong Lv, 2021, Journal of Gastrointestinal Surgery.

Critical role of KRAS mutation in pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2018, Translational Cancer Research.

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Zuqiang Liu, J. Long, Xianjun Yu, 2016, HPB.